Hakutulokset - Thomas Vanwolleghem

Tarkenna hakua
  1. 1
    Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma

    Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma Tekijä Stijn Van Hees, P. Michielsen, Thomas Vanwolleghem

    Julkaistu 2016
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV

    Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV Tekijä Thomas Vanwolleghem, Zwier M. A. Groothuismink, Kim Kreefft, Magdeleine Hung, Nikolai Novikov, André Boonstra

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

    Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial Tekijä Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem, Mamadou Dramé, Frédéric Clément, Eliane Hons, Jeanne‐Marie Devaster, Geert Leroux‐Roels

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain

    Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain Tekijä Thomas Vanwolleghem, Jens Bukh, Philip Meuleman, Isabelle Desombere, Jean‐Christophe Meunier, Harvey J. Alter, Robert H. Purcell, Geert Leroux‐Roels

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    <i>In vivo</i>evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

    <i>In vivo</i>evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus Tekijä Philip Meuleman, Jens Bukh, Lieven Verhoye, Ali Farhoudi, Thomas Vanwolleghem, Richard Y. Wang, Isabelle Desombere, Harvey J. Alter, Robert H. Purcell, Geert Leroux‐Roels

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity

    Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity Tekijä Joe Grove, Thierry Huby, Zania Stamataki, Thomas Vanwolleghem, Philip Meuleman, Michelle J. Farquhar, Anne Schwarz, Martine Moreau, James S. Owen, Geert Leroux‐Roels, Peter Balfe, Jane A. McKeating

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection

    Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection Tekijä Martijn D. B. van de Garde, Suzan D. Pas, Guido van der Net, Robert A. de Man, Albert D. M. E. Osterhaus, Bart L. Haagmans, André Boonstra, Thomas Vanwolleghem

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Cell culture-grown hepatitis C virus is infectious <i>in vivo</i> and can be recultured <i>in vitro</i>

    Cell culture-grown hepatitis C virus is infectious <i>in vivo</i> and can be recultured <i>in vitro</i> Tekijä Brett D. Lindenbach, Philip Meuleman, Alexander Ploß, Thomas Vanwolleghem, Andrew J. Syder, Jane A. McKeating, Robert E. Lanford, Stephen M. Feinstone, Marian Major, Geert Leroux‐Roels, Charles M. Rice

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis

    Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis Tekijä Mikhaïl A. Van Herck, Luisa Vonghia, Wilhelmus J. Kwanten, Yvon Julé, Thomas Vanwolleghem, Didier G. Ebo, P. Michielsen, Joris G. De Man, Lúcio Gama, Benedicte Y. De Winter, Sven Francque

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study

    Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study Tekijä Christian Jansen, Christopher Bogs, Wim Verlinden, Maja Thiele, Philipp T. Möller, Jan Görtzen, Jennifer Lehmann, Thomas Vanwolleghem, Luisa Vonghia, Michael Praktiknjo, Johannes Chang, Aleksander Krag, Christian P. Strassburg, Sven Francque, Jonel Trebicka

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Inflammatory Monocytes Recruited to the Liver within 24 Hours after Virus-Induced Inflammation Resemble Kupffer Cells but Are Functionally Distinct

    Inflammatory Monocytes Recruited to the Liver within 24 Hours after Virus-Induced Inflammation Resemble Kupffer Cells but Are Functionally Distinct Tekijä Dowty Movita, Martijn D. B. van de Garde, Paula J. Biesta, Kim Kreefft, Bart L. Haagmans, Elina I. Zúñiga, Florence Herschke, Sandra De Jonghe, Harry L.A. Janssen, Lúcio Gama, André Boonstra, Thomas Vanwolleghem

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

    JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection Tekijä Fabien Zoulim, Oliver Lenz, Joris Vandenbossche, Willem Talloen, Thierry Verbinnen, Iurie Moscalu, Adrian Streinu‐Cercel, Stefan Bourgeois, Marı́a Buti, Javier Crespo, J.M. Pascasio, Christoph Sarrazin, Thomas Vanwolleghem, Umesh Shukla, John Fry, Jeysen Yogaratnam

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2

    JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2 Tekijä Kosh Agarwal, Marı́a Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourlière, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas N. Kakuda, Cristiana Mayer, John Jezorwski, Daniel G. Muenz, Maria Beumont, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon‐Domanec

    Julkaistu 2024
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

    The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon... Tekijä Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, Stefan Bourgeois, Jean‐Pierre Mulkay, Thomas Vanwolleghem, Wim Verlinden, C. Brixco, Jochen Decaestecker, Chantal de Galocsy, Filip Janssens, Lode Van Overbeke, Christophe Van Steenkiste, F D’Heygere, Mike Cool, K. Wuyckens, Frederik Nevens, Geert Robaeys

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after <scp>HB</scp>eAg seroconversion is associated with high relapse rates and fatal outcomes

    Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after <scp>HB</scp>eAg seroconversion is associated with high relapse rates and fatal outcomes Tekijä Stijn Van Hees, Stefan Bourgeois, Hans Van Vlierberghe, Thomas Sersté, Sven Francque, P. Michielsen, D. Sprengers, Hendrik Reynaert, Jean Henrion, Sergio Negrin Dastis, Jean Delwaide, Luc Lasser, Jochen Decaestecker, Hans Orlent, Filip Janssens, Geert Robaeys, Isabelle Colle, Peter Stärkel, Christophe Moreno, Frederik Nevens, Thomas Vanwolleghem

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Screening for therapeutic trials and treatment indication in clinical practice: <scp>MACK</scp>‐3, a new blood test for the diagnosis of fibrotic <scp>NASH</scp>

    Screening for therapeutic trials and treatment indication in clinical practice: <scp>MACK</scp>‐3, a new blood test for the diagnosis of fibrotic <scp>NASH</scp> Tekijä Jérôme Boursier, Rodolphe Anty, Luisa Vonghia, Valérie Moal, Thomas Vanwolleghem, Clémence M. Canivet, S. Michalak, Stéphanie Bonnafous, P. Michielsen, Frédéric Oberti, Antonio Iannelli, L. Van Gaal, Stéphanie Patouraux, Odile Blanchet, An Verrijken, Philippe Gual, M.C. Rousselet, Ann Driessen, Gilles Hunault, Sandrine Bertrais, Albert Tran, Paul Calès, Sven Francque

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network

    Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network Tekijä A. Wranke, Cirley Maria de Oliveira Lobato, Emanoil Ceausu, George Ν. Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Onur Keskın, George Sebastian Gherlan, Minaam Abbas, Patrick Ingiliz, Marion Muche, Marı́a Buti, Mathias Jachs, Thomas Vanwolleghem, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, Petra Dörge, Heiner Wedemeyer

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin

    Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin Tekijä Philippe Lefèbvre, Fanny Lalloyer, Eric Baugé, Michał Pawlak, Céline Gheeraert, Hélène Dehondt, Jonathan Vanhoutte, Eloïse Woitrain, Nathalie Hennuyer, Claire Mazuy, Marie Bobowski, Francesco Paolo Zummo, Bruno Derudas, Ann Driessen, Guy Hubens, Luisa Vonghia, Wilhelmus J. Kwanten, P. Michielsen, Thomas Vanwolleghem, Jérôme Eeckhoute, An Verrijken, Luc Van Gaal, Sven Francque, Bart Staels

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism

    TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism Tekijä Armando Andres Roca Suarez, Marie‐Laure Plissonnier, Xavier Grand, Maud Michelet, Guillaume Giraud, Maria Saez‐Palma, A. Dubois, Sarah Heintz, Audrey Diederichs, Nicolaas Van Renne, Thomas Vanwolleghem, Stéphane Daffis, Li Li, Nikita Kolhatkar, Yao‐Chun Hsu, Jeffrey J. Wallin, Audrey Lau, Simon P. Fletcher, Michel Rivoire, Massimo Levrero, Barbara Testoni, Fabien Zoulim

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (<scp>HDIN</scp>)

    Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (<scp>HDIN</scp>) Tekijä A. Wranke, Lourdes Maria Pinheiro Borzacov, Raymundo Paraná, Cirley Lobato, Saeed Hamid, Emanoil Ceaușu, George Ν. Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Farheen Lubna, Minaam Abbas, Patrick Ingiliz, Marı́a Buti, Péter Ferenci, Thomas Vanwolleghem, Tonya Hayden, Naranjargal Dashdorj, Adriana Moţoc, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, Michael P. Manns, Heiner Wedemeyer, Svenja Hardtke

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: